Key result
Supraventricular tachycardia is a common neonatal emergency, most often caused by atrioventricular reentrant tachycardia, which has a high rate of spontaneous resolution and is primarily managed with pharmacological agents.
This review provides a comprehensive overview of the mechanisms, electrocardiographic diagnosis, and acute and maintenance pharmacological management of neonatal supraventricular tachycardia.
Pharmacological therapy remains first-line for neonatal SVT with expected spontaneous resolution; leaves open optimal duration and ablation criteria.
Supraventricular tachycardia (SVT) is one of the most common conditions requiring emergency cardiac care in neonates. Atrioventricular reentrant tachycardia utilizing an atrioventricular bypass tract is the most common form of SVT presenting in the neonatal period. There is high likelihood for spontaneous resolution for most of the common arrhythmia substrates in infancy. Pharmacological agents remain as the primary therapy for neonates.
No takes yet. Share an insight, caveat, or question.
Srinivasan et al. (2019) conducted a review in Neonatal supraventricular tachycardia. Pharmacological therapy and catheter ablation was evaluated. Supraventricular tachycardia is a common neonatal emergency, most often caused by atrioventricular reentrant tachycardia, which has a high rate of spontaneous resolution and is primarily managed with pharmacological agents.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: